BioSpace News Archive

A report from Milliman, Inc. about disparities between physical and behavioral healthcare for both in-network access and provider reimbursement rates underscores NABH’s position that unnecessary barriers continue to deny access to behavioral healthcare for patients who need it..

Universal Health Services, Inc. announced that its Board of Directors voted to pay a cash dividend of $0.20 per share on December 19, 2019 to shareholders of record as of December 5, 2019..

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an agreement with LabCorp® (NYSE: LH) to extend their current QIAGEN Clinical Insights (QCI) license with QIAGEN’s Human Gene Mutation Database (HGMD) of human genetic variants, the world’s largest database of inherited disease mutations.

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019, at 2:30 p.m. EST in New York City.

Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders.

Celgene Corporation announced that following the completion of Celgene’s acquisition by Bristol-Myers Squibb Company, Bristol-Myers Squibb and Celgene plan to transfer the listing of Celgene’s contingent value rights that are related to Celgene’s ABRAXANE® product from the NASDAQ Global Market to the New York Stock Exchange

Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it held its annual general and special meeting of shareholders (the “Meeting”) earlier today in Denver, Colorado and that all resolutions were overwhelmingly approved by shareholders of the Company

Phio Pharmaceuticals Corp. announced the closing of its previously announced public offering of 10,000,000 shares of its common stock at a public offering price of $0.10 per share.

We believe health care transcends one portfolio and, as such, we wish to welcome new and returning members to Cabinet, including the Minister of Finance, Bill Morneau, Minister of Intergovernmental Affairs, Chrystia Freeland, Minister of Indigenous Services, Marc Miller, Minister of Seniors, Deb Schulte, and Minister of Environment and Climate Change, Jonathan Wilkinson.

Therapix Biosciences Ltd. announced that it received a written Notice of Delisting from the Listing Qualifications Department of The Nasdaq Capital Market (“Nasdaq”).